In the BioHarmony Drug Report Database
Maftivimab
Inmazeb (maftivimab) is an antibody pharmaceutical. It is currently being investigated in clinical studies.
Trade Name
|
Inmazeb |
|---|---|
Common Name
|
maftivimab |
ChEMBL ID
|
CHEMBL4298184 |
Indication
|
|
Drug Class
|
Monoclonal antibodies: viruses, antiviral indications |
Image (chem structure or protein)
